The prevalence and risk of metabolic syndrome and its components among people with posttraumatic stress disorder: A systematic review and meta-analysis

Metabolism: Clinical and Experimental

Volumn 64, Issue 8, 2015, Pages 926-933

  Rosenbaum, Simon ^a   Stubbs, Brendon ^b   Ward, Philip B ^a   Steel, Zachary ^a   Lederman, Oscar ^a   Vancampfort, Davy ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cardiovascular disease; Glucose; Lipids; Metabolic syndrome; PTSD

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; AGE; GENDER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; META ANALYSIS; METABOLIC SYNDROME X; POPULATION; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; COMPLICATION; RISK;

HUMANS; METABOLIC SYNDROME X; PREVALENCE; RISK; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84942883916     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2015.04.009     Document Type: Review

References (56)

1. Boscarino JA. Posttraumatic stress disorder and mortality among U.S. Army veterans 30 years after military service. Ann Epidemiol 2006;16:248-56.
2. Boscarino JA. Psychobiologic predictors of disease mortality after psychological trauma: implications for research and clinical surveillance. J Nerv Ment Dis 2008;196:100-7.
3. Xue Y, Taub PR, Iqbal N, Fard A, Wentworth B, Redwine L, et al. Cardiac biomarkers, mortality, and post-traumatic stress disorder in military veterans. Am J Cardiol 2012;109: 1215-8.
4. Pacella ML, Hruska B, Delahanty DL. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J Anxiety Disord 2013;27:33-46.
5. Ahmadi N, Hajsadeghi F, Mirshkarlo HB, Budoff M, Yehuda R, Ebrahimi R. Post-traumatic stress disorder, coronary atherosclerosis, and mortality. Am J Cardiol 2011;108:29-33.
6. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119: 812-9.
7. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-14.
8. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-32.
9. Expert Panel on Detection E.. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
10. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112:2735-52.
11. Alberti K, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006;23:469-80.
12. WHO.Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organization; 1999.
13. Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, et al. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;NationalHeart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
14. MitchellAJ, VancampfortD, DeHerdtA, YuW, De Hert M. Is the prevalence of metabolic syndrome andmetabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull 2013;39:295-305.
15. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr Bull 2013;39: 306-18.
16. Vancampfort D, WampersM, MitchellAJ, Correll CU, HerdtA, Probst M, et al.Ameta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls.World Psychiatry 2013;12:240-50.
17. VancampfortD, CorrellCU, Wampers M, Sienaert P, Mitchell A, De Herdt A, et al. Metabolic syndrome andmetabolic abnormalities in patients withmajor depressive disorder: ameta-analysis of prevalences andmoderating variables. Psychol Med 2014;44: 2017-28.
18. Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: ameta-analysis of prevalence rates andmoderators. Am J Psychiatry 2013;170:265-74.
19. Bartoli F, Carra G, Crocamo C, Carretta D, Clerici M. Metabolic syndrome in people suffering from posttraumatic stress disorder: a systematic review and meta-analysis. Metab Syndr Relat Disord 2013;11:301-8.
20. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283: 2008-12.
21. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9.
22. Association AP. Diagnostic and Statistical Manual of Mental Disorders, Text Revision (DSM-IV-TR). American Psychiatric Association; 2000.
23. OrganizationWH. The ICD-10 Classification of Mental and Behavioural Disorders-Diagnostic Criteria for Research (Geneva, World Health Organization); 1993.
24. EggerM, Smith GD, Schneider M, Minder C. Bias inmeta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
25. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994: 1088-101.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
27. Ahmadi N, Yehuda R, Ebrahimi R, Vaidya N. Post-traumatic stress disorder, metabolic syndrome and mortality: the role of selective serotonin reuptake inhibitor and tricyclic antidepressants. J Neuropsychiatry Clin Neurosci 2014;26:6-7.
28. Babic R, Maslov B, Babic D, Vasilj I. The prevalence of metabolic syndrome in patient with posttraumatic stress disorder. Psychiatr Danub 2013;25(Suppl. 1):45-50.
29. Weiss T, Skelton K, Phifer J, Jovanovic T, Gillespie CF, Smith A, et al. Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population. Gen Hosp Psychiatry 2011;33:135-42.
30. Linnville S, Hoyt RE, Moore JL, Segovia F, Hain RE. Posttraumatic stress disorder and metabolic syndrome: retrospective study of repatriated prisoners of war. Mil Med 2011;176:369-74.
31. Heppner PS, Crawford EF, Haji UA, Afari N, Hauger RL, Dashevsky BA, et al. The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med 2009;7:1.
32. Jin H, Lanouette NM, Mudaliar S, Henry R, Folsom DP, Khandrika S, et al. Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome. J Clin Psychopharmacol 2009;29:210-5.
33. Jakovljevic M, Babic D, Crncevic Z, Martinac M, Maslov B, Topic R. Metabolic syndrome and depression in war veterans with post-traumatic stress disorder. Psychiatr Danub 2008;20: 406-10.
34. Maslov B, Jakovljevic M, Crncevic Z, Ostojic L, Marcinko D, Babic D, et al. Metabolic syndrome and schizophrenia from integrative medicine perspective. Psychiatr Danub 2008;20: 384-9.
35. Violanti JM, Hartley TA, Charles LE, Fekedulegn D, Andrew ME, Mnatsakanova A, et al. Police trauma and cardiovascular disease: association between PTSD symptoms and metabolic syndrome. Int J Emerg Ment Health 2006;8:227-38.
36. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287: 356-9.
37. Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
38. Vaccarino V, Goldberg J, Rooks C, Shah AJ, Veledar E, Faber TL, et al. Post-traumatic stress disorder and incidence of coronary heart disease: a twin study. J Am Coll Cardiol 2013; 62:970-8.
39. Leslie DL, Mohamed S, Rosenheck RA. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system. Psychiatr Serv 2009;60:1175-81.
40. Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 2010:e04.
41. McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms; 2006.
42. Hennings MJ, Schaaf L, Fulda S. Glucose metabolism and antidepressant medication. Curr Pharm Des 2012;18:5900-19.
43. Knol M, Derijks H, Geerlings M, Heerdink E, Souverein P, Gorter K, et al. Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiol Drug Saf 2008;17:577-86.
44. Mojtabai R. Antidepressant use and glycemic control. Psychopharmacology (Berl) 2013;227:467-77.
45. Farr OM, Sloan DM, Keane TM, Mantzoros CS. Stress-and PTSD-associated obesity and metabolic dysfunction: a growing problem requiring further research and novel treatments. Metabolism 2014;63:1463-8.
46. Boscarino JA. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann N Y Acad Sci 2004;1032:141-53.
47. Dedert EA, Calhoun PS, Watkins LL, Sherwood A, Beckham JC. Posttraumatic stress disorder, cardiovascular, and metabolic disease: a review of the evidence. Ann Behav Med 2010;39: 61-78.
48. Eraly SA, Nievergelt CM, Maihofer AX, Barkauskas DA, Biswas N, Agorastos A, et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014;71:423-31.
49. Li H, Li X, Smerin SE, Zhang L, Jia M, Xing G, et al. Mitochondrial gene expression profiles andmetabolic pathways in the amygdala associated with exaggerated fear in an animal model of PTSD. Front Neurol 2014:5.
50. Nevell L, Zhang K, Aiello AE, Koenen K, Galea S, Soliven R, et al. Elevated systemic expression of ER stress related genes is associated with stress-related mental disorders in the Detroit Neighborhood Health Study. Psychoneuroendocrinology 2014;43:62-70.
51. Zen AL, Whooley MA, Zhao S, Cohen BE. Post-traumatic stress disorder is associated with poor health behaviors: findings from the heart and soul study. Health Psychol 2012; 31:194-201.
52. Fu SS, McFall M, Saxon AJ, BeckhamJC, Carmody TP, Baker DG, et al. Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res 2007;9:1071-84.
53. Blanco C, Xu Y, Brady K, Pérez-Fuentes G, Okuda M, Wang S. Comorbidity of posttraumatic stress disorder with alcohol dependence among US adults: results from National Epidemiological Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2013;132:630-8.
54. Carmassi C, Bertelloni CA, Massimetti G, Miniati M, Stratta P, Rossi A, et al. Impact of DSM-5 PTSD and gender on impaired eating behaviors in 512 Italian earthquake survivors. Psychiatry Res 2015;225:64-9.
55. Godfrey KM, Lindamer LA, Mostoufi S, Afari N. Posttraumatic stress disorder and health: a preliminary study of group differences in health and health behaviors.Ann Gen Psychiatry 2013;12:30.
56. Rosenbaum S, Sherrington C, Tiedemann A. Exercise augmentation compared with usual care for post-traumatic stress disorder: a randomized controlled trial. Acta Psychiatr Scand 2015;131:350-9.